Last reviewed · How we verify

NCT04666285: SWS_COVID-19

Southampton Women's Survey COVID-19 Study

Completed Last updated 4 October 2021
What this trial tests

trial testing Experience of pandemic in Mental Health Wellness 1 in 832 participants. Completed in 1 August 2021.

Timeline
15 February 2021
Primary endpoint
1 August 2021
1 August 2021

Quick facts

Lead sponsorUniversity of Southampton
StatusCompleted
Study typeOBSERVATIONAL
Enrollment832
Start date15 February 2021
Primary completion1 August 2021
Estimated completion1 August 2021
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Southampton

Who can join

Adults 12 to 57, any sex, with Mental Health Wellness 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current COVID-19 pandemic has brought many challenges with implications for wellbeing and mental health. The Southampton Women's Survey provides the opportunity to understand influences on these important outcomes amongst women and their offspring in the context of an established longitudinal cohort study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mental Health Wellness 1

Currently open trials in the same condition.

Other University of Southampton trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04666285.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing